Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H14F3N3O3S |
| Molecular Weight | 385.361 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(OCC(F)(F)F)C=CN=C1C[S+]([O-])C2=NC3=C(N2)C=CC(O)=C3
InChI
InChIKey=IDCLTMRSSAXUNY-UHFFFAOYSA-N
InChI=1S/C16H14F3N3O3S/c1-9-13(20-5-4-14(9)25-8-16(17,18)19)7-26(24)15-21-11-3-2-10(23)6-12(11)22-15/h2-6,23H,7-8H2,1H3,(H,21,22)
| Molecular Formula | C16H14F3N3O3S |
| Molecular Weight | 385.361 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:56:54 GMT 2025
by
admin
on
Mon Mar 31 21:56:54 GMT 2025
|
| Record UNII |
N5ROU3WS91
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9800271
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | |||
|
N5ROU3WS91
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | |||
|
131926-98-2
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
the 5-hydroxylation of lansoprazole is primarily catalyzed by CYP2C19.
|
||
|
PARENT -> METABOLITE |
These metabolites have very little or no antisecretory activity.
|